Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham Study

Stroke

Volumn 32, Issue 11, 2001, Pages 2575-2579

  Rost, Natalia S ^b   Wolf, Philip A ^a,b   Kase, Carlos S ^a,b   Kelly Hayes, Margaret ^a,b   Silbershatz, Halit ^b   Massaro, Joseph M ^b   D'Agostino, Ralph B ^b   Franzblau, Carl ^b   Wilson, Peter W F ^a,b  

^a Boston University School of Medicine ^*

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; C reactive protein; Inflammation; Ischemic stroke; Risk factors; TIA

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; BLOOD; BRAIN ISCHEMIA; FOLLOW UP; UNITED STATES;

ADULT; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW-UP STUDIES; HUMAN; ISCHEMIC ATTACK, TRANSIENT; MALE; MASSACHUSETTS; MIDDLE AGE; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0035170373     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1101.098151     Document Type: Article

References (38)

1. Fibrinogen and cardiovascular risk
2. Leukocytes and the risk of ischemic diseases
3. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
4. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction
5. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke
6. Viral and bacterial infections in patients with acute myocardial infarction
7. Elevation of C-reactive protein in "active" coronary artery disease
8. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction
9. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy
10. Production of C-reactive protein and risk of coronary events in stable and unstable angina
11. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
12. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
13. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
14. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
15. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
16. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
17. C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons
18. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study
19. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease
20. C-reactive protein, a sensitive marker for inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsberg Cohort Study, 1984 to 1992
21. Some risk factors related to the annual incidence of cardiovascular disease and death using polled repeated biennial measurements
22. Epidemiology of stroke
23. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Heart Study 30-Year Follow-Up
24. Epidemiology of stroke
25. The pathogenesis of coronary artery disease and the acute coronary syndromes
26. Atherosclerosis: An inflammatory disease
27. Acute-phase proteins and other systemic responses to inflammation
28. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease
29. Metabolic risk factors for coronary heart disease: Current and future prospects
30. Evaluating novel cardiovascular risk factors: Can we better predict heart attacks?
31. The acute phase response
32. Raised C-reactive protein levels in serum from smokers
33. Inflammation in cardiovascular disease: Cart, horse, or both?
34. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects
35. The role of inflammation in cardiovascular disease